PaxVax Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PaxVax Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10882
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PaxVax Inc (PaxVax) is a vaccine company that develops and commercializes specialty vaccines against infectious diseases. The company develops scalable, and oral vaccines. Its activities include early-stage preclinical research and development, clinical study support, drug product manufacturing, drug substance sterile fill and finish, and packaging infrastructure. PaxVax commercializes vaccines for cholera, HIV, zika, endemic infectious diseases, chikungunya, hepatitis A, adenovirus and dengue. The company’s vector vaccines are based on adenovirus serotypes 4 and 7 and the A549 cell substrate. It operates through its laboratory and manufacturing facilities located in San Diego, California; and Thorishaus, Switzerland. PaxVax is headquartered in Redwood City, California, the US.

PaxVax Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PaxVax Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PaxVax Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PaxVax Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
PaxVax Acquires Vivotif from Crucell 10
Venture Financing 11
PaxVax Raises USD12 Million in Extended Series B Financing 11
PaxVax Raises USD50 Million in Venture Debt Financing 12
PaxVax Raises US$6 Million In Venture Financing 13
PaxVax Raises US$22 Million In Series B Financing 14
Private Equity 15
Cerberus Capital Invests USD105 Million in PaxVax 15
Partnerships 16
PaxVax and TerahVax Korea Enter into Distribution Agreement 16
PaxVax Enters into Distribution Agreement with Seqirus 17
Valneva Enters into Distribution Agreement with PaxVax 18
PaxVax Enters into Distribution Agreement with Novartis 19
PaxVax Enters into Distribution Agreement with BioCSL 20
PaxVax Enters into Distribution Agreement with Valneva 21
Licensing Agreements 22
PaxVax Enters into Licensing Agreement with National Institutes of Health 22
PaxVax Enters into Licensing Agreement with Leukocare 23
PaxVax Enters into Licensing Agreement with University Of California, San Diego 24
Acquisition 25
Emergent BioSolutions Acquires PaxVax from Cerberus Capital Management for USD270 Million 25
PaxVax Inc – Key Competitors 27
PaxVax Inc – Key Employees 28
PaxVax Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Government and Public Interest 30
Jun 29, 2018: Same Vaccine Concept for Ebola Appears Effective Against Nipah Virus 30
Clinical Trials 31
May 04, 2018: FDA Grants PaxVax Fast Track Designation for its Chikungunya Vaccine 31
Apr 25, 2018: PaxVax Announces the Initiation of Phase 2b Trial for its Chikungunya Vaccine 32
May 08, 2017: PaxVax Initiates Clinical Trials of a Modernized Adenovirus Vaccine in Collaboration with the U.S. Army Medical Materiel Development Activity and the Walter Reed Army Institute of Research to Protect U.S. Military Personnel 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
PaxVax Inc, Pharmaceuticals & Healthcare, Key Facts 2
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PaxVax Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PaxVax Inc, Deals By Therapy Area, 2012 to YTD 2018 8
PaxVax Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PaxVax Acquires Vivotif from Crucell 10
PaxVax Raises USD12 Million in Extended Series B Financing 11
PaxVax Raises USD50 Million in Venture Debt Financing 12
PaxVax Raises US$6 Million In Venture Financing 13
PaxVax Raises US$22 Million In Series B Financing 14
Cerberus Capital Invests USD105 Million in PaxVax 15
PaxVax and TerahVax Korea Enter into Distribution Agreement 16
PaxVax Enters into Distribution Agreement with Seqirus 17
Valneva Enters into Distribution Agreement with PaxVax 18
PaxVax Enters into Distribution Agreement with Novartis 19
PaxVax Enters into Distribution Agreement with BioCSL 20
PaxVax Enters into Distribution Agreement with Valneva 21
PaxVax Enters into Licensing Agreement with National Institutes of Health 22
PaxVax Enters into Licensing Agreement with Leukocare 23
PaxVax Enters into Licensing Agreement with University Of California, San Diego 24
Emergent BioSolutions Acquires PaxVax from Cerberus Capital Management for USD270 Million 25
PaxVax Inc, Key Competitors 27
PaxVax Inc, Key Employees 28
PaxVax Inc, Other Locations 29

List of Figures
PaxVax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PaxVax Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PaxVax Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PaxVax Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BEML Limited:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "BEML Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows a st …
  • PTT Public Company Limited (PTT):企業のM&A・提携動向(発電分野)
    Summary PTT Public Company Limited (PTT) is an integrated national oil and gas, and petrochemical company. It operates in oil and natural gas, coal, power, and infrastructure businesses. The company carries out oil and natural gas exploration and production; oil refining; procurement, processing, tr …
  • Synthomer plc (SYNT):企業財務及び戦略的SWOT分析
    Summary Synthomer plc (Synthomer) formerly Yule Catto & Co plc is a chemical company that manufactures polymers, pharmaceutical ingredients and impact chemicals. The company’s products include vinyl dispersions, styrene butadiene latex, nitrile butadiene latex, latex compounds and auxiliaries, and o …
  • Ontario Power Generation Inc:企業の戦略的SWOT分析
    Ontario Power Generation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Intellect Neurosciences, Inc. (formerly GlobePan Resources, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Intellect Neurosciences, Inc. ( …
  • Oceania Cruises, Inc.:企業の戦略・SWOT・財務分析
    SummaryOceania Cruises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • Community Windpower Limited:企業のM&A・提携動向(エネルギー分野)
    Summary Community Windpower Limited (Community Windpower) is a renewable energy company. The company designs, develops, constructs and operates wind farms for local energy requirement. It operates various wind power projects that include Dalry Community Windfarm in North Ayrshire, Aikengall Communit …
  • BioView Ltd (BIOV)-医療機器分野:企業M&A・提携分析
    Summary BioView Ltd (BioView) is a medical device company that develops, manufactures and markets automated cell imaging and analysis solutions, which incorporate proprietary imaging, analysis and review technology. The technology provides automatic control of fully motorized fluorescent and bright- …
  • Jorf Lasfar Energy Company, S.A.:企業のM&A・提携動向(発電分野)
    Summary Jorf Lasfar Energy Company, S.A. (JLEC), a subsidiary of Abu Dhabi National Energy Company is a power company that generates and supplies power in Morocco. The company owns and operates coal fired power station. It also has coal storage facilities, conveyors, fuel tanks, water supply station …
  • Nonin Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Nonin Medical Inc (Nonin) is a medical device company that provides medical monitoring solutions. The company provides noninvasive physiological monitoring devices for health professionals and consumers. Its products include pulse oximeters and sensors, regional oximeters and sensors, finger …
  • Biomunex Pharmaceuticals:製薬・医療:M&Aディール及び事業提携情報
    Summary Biomunex Pharmaceuticals (Biomunex) is a biopharmaceutical company that discovers and develops bispecific antibody therapeutics for the treatment of cancer. The company’s portfolio of pipeline products incldes BMX-101, which is developed as a novel immunotherapeutic treatment for relapsed an …
  • miacom diagnostics GmbH:企業のM&A・提携動向(医療機器分野)
    Summary miacom diagnostics GmbH (miacom) is a molecular diagnostic company that develops and distributes molecular diagnostic tests. The company’s products include hemoFISH, respiFISH, FISH Probes, ancillaries and reagents. It offers solutions for every workstation such as combined hotplate or hybri …
  • Groundstar Resources Limited (GSA):企業の財務及び戦略的SWOT分析
    Summary Groundstar Resources Limited (Groundstar) is an oil and gas company that acquires, develops and produces oil and gas properties. The company has assets such as West Kom Ombo Block and West Esh El Mellaha Block in Africa; and Takutu Basin PPL in South America. It evaluates seismic and well da …
  • Arise AB (ARISE):企業のM&A・提携動向(発電分野)
    Summary Arise AB (Arise), formerly Arise Windpower AB, is a wind power generating company. It specializes in marketing and selling electricity, generated from land-based wind turbines. The company is into prospecting and concession management, to the construction and operation of the turbines, as we …
  • Astino Bhdの企業概要及び財務/SWOT分析
    Astino Bhd Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts …
  • NaiKun Wind Energy Group Inc. (NKW):企業概要、財務及び戦略的SWOT分析
    Summary Naikun Wind Energy Group Inc. (Naikun) is a wind energy service provider. The company develops offshore wind energy projects to generate electricity. Its engineering activities include installation of a meteorological station to collect wind, wave and climate information, collection of envir …
  • Berner Oberland-Bahnen AG:企業の戦略・SWOT・財務分析
    SummaryBerner Oberland-Bahnen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …
  • Triveni Engineering and Industries Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Triveni Engineering and Industr …
  • Indianapolis Power & Light Co:電力:M&Aディール及び事業提携情報
    Summary Indianapolis Power & Light Co (IPL), a subsidiary of IPALCO Enterprises Inc, is an integrated electric utility. The company generates, transmits, distributes, and sells electric energy. It produces electricity from coal, oil, and natural gas sources. IPL owns and operates power plants in Ind …
  • Madalena Energy Inc. (MVN):企業の財務及び戦略的SWOT分析
    Summary Madalena Energy Inc. (Madalena) is an oil and gas company that provides international and domestic upstream oil and gas services. The company explores, develops and produces crude oil, natural gas liquids and natural gas. Its oil and gas properties include Coiron Amargo Block, Curamhuele Blo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆